scholarly journals Cost-Effectiveness Analysis of Landiolol, an Ultrashort-Acting Beta-Blocker, for Prevention of Postoperative Atrial Fibrillation for the Germany Health Care System

2020 ◽  
Vol 34 (4) ◽  
pp. 888-897
Author(s):  
Evelyn Walter ◽  
Matthias Heringlake
Sign in / Sign up

Export Citation Format

Share Document